News

Shenvi and Roberts are recognized for their contributions in organic synthesis and the development of medicinally useful substances.

A small molecule that activates the immune protein STING shows promising results against tumors.

These molecules, called terpenes, are potential starting points for new drugs and other high-value products, marking an important development for multiple industries.

Electron microscopy showed that the coronavirus spikes maintained the desired shape in the vaccine, which should help stimulate an appropriate immune response.

Unlike traditional vaccine clinical trials, this study provided a clear and comprehensive picture of a vaccine’s antibody-response landscape.

Collaborating labs at Scripps Research developed a way to seamlessly create the compound's complex structure.

Chemists at Scripps Research have reported a promising but mysterious finding in experiments with a potential vaccine that is meant to combat heroin addiction.

Advanced chemistry techniques reveal thousands of sites on immune proteins where drug molecules may be able to bind, opening new possibilities for treating immune-driven conditions.

Scripps Research is collaborating with frontline workers at the San Diego Metropolitan Transit System and Scripps Health to help detect and track viral illnesses in near real-time.

The compound hits a vulnerable spot on multiple strains of the flu, attacking the virus in a whole new way.

The $25,000 award will support scientific research in organic chemistry, with a view to enabling drug discovery.

Scientists reveal a new role for cells that already are known to be implicated in many other brain-based diseases, including Alzheimer’s and Huntington’s.

A new study reveals how two key neural circuits dictate the choice between social approach and avoidance.  The findings will enable researchers to evaluate social interventions in autism.

Findings of the new study support many vaccine strategies currently being used to tackle the new coronavirus.

The award will support Erb’s drug discovery platform to identify novel cancer therapies.

Blackmond joins a long line of respected scholars defined as being “Nunquam otiosus,” or “never idle,” the motto of the academy.

The program helps prepare and support talented new investigators at pivotal moments in their career.

Huntington’s disease progression involves a promoter of inflammation and autophagy, the cellular housekeeping process, a new study finds.  

The Board of Overseers, one of two governing boards at Scripps Research, provides expertise and leadership to advance the institute’s mission.

The rich data stored in electronic medical records may offer clues to better care for those diagnosed with coronavirus disease.

Some common strains of influenza are able to mutate to evade some of the broad-acting antibodies that could be elicited by a universal flu vaccine. 

With an initial focus on screening local healthcare workers and first responders, the study seeks to understand the prevalence of coronavirus infections in the community.

Promoting a healthy gut microbiome may be a powerful strategy for lowering cholesterol and other heart attack risk factors.

A team led by Scripps Research has discovered antibodies in the blood of recovered COVID-19 patients that provide powerful protection against the coronavirus that causes the disease.